NCT03993275

Brief Summary

Exergames are games that require physical movements and are used with a therapeutic purpose, e.g. to improve strength, balance or flexibility. Exergames rely on technologies that track body movements and reaction, to perform exercises in a persuasive environment. Exergames are increasingly used in rehabilitation to improve motor function and independence of patients. Exergames are increasingly used for self-regulated exercise. However, usability of the MMGO is reduced by the fact that 1) therapists are needed to choose exercises and 2) adapt the exercise program depending on patients' ability level, and 3) patients' motivation reduces after about 5 sessions if exercises are not adapted and variation of exercises is low. The planned study aims to overcome the given limitations and thus improve usability. Using routine data of patients exercising with MMGO and clinical outcome measures this study will investigate the relationship between scores on the MMGO and on clinical outcome measures and how these scores change over time. In addition, the study will determine the relative difficulty levels of each exercise and its difficulty level in relation to participants' balance ability.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
84

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Oct 2018

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 10, 2018

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

May 6, 2019

Completed
2 months until next milestone

First Posted

Study publicly available on registry

June 20, 2019

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 15, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 15, 2020

Completed
Last Updated

May 13, 2020

Status Verified

May 1, 2020

Enrollment Period

1.3 years

First QC Date

May 6, 2019

Last Update Submit

May 12, 2020

Conditions

Keywords

Trunk ControlExergames

Outcome Measures

Primary Outcomes (7)

  • Game score of performed MindMotion GO Exergames

    For each game the MindMotion GO device provides a score (0=poorest -100=best performance) after completion of the game.

    3-4 weeks

  • Change in Balance (Berg Balance Scale)

    The Berg Balance Scale measures stattic balance and fall risk in adults. It consists of The Berg Balance Scale is used to asses Balance. The Scale consists of 14 items, for each item the minimum score is 0 points, the maximum score is 4 points. A total amount of 56 points can be achieved on the Berg Balance Scale which indicates a normal balance for adults. A score lower than 45 points in elderly indicates that individuals may be at greater risk of falling.

    Baseline, weekly, and after 3-4 weeks of training

  • Change in trunk control and sitting Balance (Trunk Impairment Scale)

    The Trunk Impairment Scale assesses stattic and dynamic sitting balance and coordination of trunk movement. The test consists of 17 items with a minimum score of 0 and a maximum score of 23 points, which is calculated by adding up the scores from the subscales (0-7 Points for static sitting Balance, 0-10 Points for dynamic sitting Balance, 0-6 Points for coordination), with a higher scores for better trunk control.

    Baseline and after 3-4 weeks of training

  • Change in mobility

    The Timed Up and GO Test assess mobility, balance, walking abaility and fall risk. The patient is asked to stand up from a chair, walk a distance of 3 meters, turn, walk back to the chair and sit down again. The performance of the patient is measured by measuring the time it takes to perform this task. With a shorter time, representing better mobility.

    Baseline and after 3-4 weeks of training

  • Change in dynamic balance during gait

    The Dynamic Gait Index assesses the ability to modify balance while walking. Eight items are scored from 0 to 4 points, showing the amount of dysfunction the patient shows in executing the tasks. The Minimum score is 0 Points, the maximum score is 24 points, indicating a better balance while walking.

    Baseline and after 3-4 weeks of training

  • Change in the perceived Walking ability

    The MS Walking scale 12, is a 12-item questionnaire to assess the impact of MS on the walking ability. The questions are scored 1 to 5, with 1 meaning no limitation and 5 meaning extreme limitation on gait related activites. The total score is calculated into percentages, with a higher percentage meaning a higher perceived impact of the MS on walking ability.

    Baseline and after 3-4 weeks of training

  • Subjective difficulty of performed MindMotion GO Exerames

    The patient is asked to score how difficult it was to perform the MindMotion GO game in question. With 0 being verry easy, and 5 being impossible to execute this game.

    3-4 weeks

Secondary Outcomes (2)

  • Change in Intrinsic Motivation during the treatment phase

    Baseline and after 3-4 weeks of training

  • Montreal cognitive assessment

    Baseline and after 3-4 weeks of training.

Study Arms (2)

Patients with Stroke

30 Patients suffering a stroke will be included in the study. After clinical measurements of balance, gait, trunk control and cognition, patients will train 2-3 times a week for on average 4 weeks with the MindMotion GO system. Afterwards, clinical measures will be repeated.

Device: MindMotion GO

Patients with Multiple Sclerosis

50 Patients suffering multiple sclerosis will be included in the study. After clinical measurements of balance, gait, trunk control and cognition, patients will train 2-3 times a week for on average 3 weeks with the MindMotion GO system. Afterwards, clinical measures will be repeated.

Device: MindMotion GO

Interventions

Patients will train trunk control and balance using the MindMotion GO device 2-3 times a week. They will perform exergames in sitting or standing, according to their balance level.

Patients with Multiple SclerosisPatients with Stroke

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

MS patients that come to the rehabiliation center for a minimum of 3 weeks rehabiliation. Patients have a EDSS score between 3.0 and 6.5 and have balance problems as shown by the BBS. Subacute stroke patients that come into Rehabiliation for a minimum of 4 weeks and show balance problems, according to the BBS.

You may qualify if:

  • Patients with a Stroke or Multiple sclerosis (EDSS 3-6.5), confirmed by a neurologist
  • Age \> 18 years
  • Referred for a minimum of 3 weeks in-patient rehabilitation
  • Reduced balance (\< 52/56 points on the Berg Balance Scale)
  • Signed informed consent

You may not qualify if:

  • Co-morbidities interfering with exergame performance, walking ability and balance (e.g. visual or cognitive impairments, psychiatric disorders, musculoskeletal problems)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Rehazentrum Valens

Valens, Canton of St. Gallen, 7317, Switzerland

Location

Related Publications (1)

  • Wiskerke E, Kool J, Hilfiker R, Sattelmayer KM, Verheyden G. Determining the Optimal Virtual Reality Exergame Approach for Balance Therapy in Persons With Neurological Disorders Using a Rasch Analysis: Longitudinal Observational Study. JMIR Serious Games. 2022 Mar 22;10(1):e30366. doi: 10.2196/30366.

MeSH Terms

Conditions

StrokeMultiple Sclerosis

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular DiseasesDemyelinating Autoimmune Diseases, CNSAutoimmune Diseases of the Nervous SystemDemyelinating DiseasesAutoimmune DiseasesImmune System Diseases

Study Officials

  • Jan Kool

    Kliniken Valens

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Physiotherapist and Researcher, MSc

Study Record Dates

First Submitted

May 6, 2019

First Posted

June 20, 2019

Study Start

October 10, 2018

Primary Completion

January 15, 2020

Study Completion

January 15, 2020

Last Updated

May 13, 2020

Record last verified: 2020-05

Locations